Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

73.16
+0.94001.30%
Post-market: 73.160.00000.00%19:30 EDT
Volume:481.75K
Turnover:35.26M
Market Cap:3.21B
PE:-67.59
High:73.93
Open:72.22
Low:71.20
Close:72.22
52wk High:91.53
52wk Low:53.89
Shares:43.88M
Float Shares:35.64M
Volume Ratio:0.64
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.26
PE(LYR):-46.01

Loading ...

Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Major Issues Report

Form 8-K - Current report
Jul 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]